Nisa Investment Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
+28,646
| New | +$1.03M | ﹤0.01% | 802 |
|
|
2024
Q2 | – | Sell |
-75,000
| Closed | -$2.28M | – | 2969 |
|
|
2024
Q1 | $2.28M | Hold |
75,000
| – | – | 0.01% | 660 |
|
|
2023
Q4 | $2.11M | Buy |
75,000
+68,900
| +1,130% | +$1.94M | 0.01% | 645 |
|
|
2023
Q3 | $166K | Sell |
6,100
-4,900
| -45% | -$133K | ﹤0.01% | 1355 |
|
|
2023
Q2 | $338K | Buy |
11,000
+6,700
| +156% | +$206K | ﹤0.01% | 1184 |
|
|
2023
Q1 | $155K | Sell |
4,300
-149,519
| -97% | -$5.39M | ﹤0.01% | 1364 |
|
|
2022
Q4 | $6.08M | Buy |
153,819
+143,660
| +1,414% | +$5.68M | 0.05% | 377 |
|
|
2022
Q3 | $415K | Buy |
+10,159
| New | +$415K | ﹤0.01% | 1091 |
|
|
2022
Q1 | – | Sell |
-9,244
| Closed | -$370K | – | 2388 |
|
|
2021
Q4 | $370K | Sell |
9,244
-1,783
| -16% | -$71.4K | ﹤0.01% | 1093 |
|
|
2021
Q3 | $399 | Buy |
+11,027
| New | +$399 | ﹤0.01% | 1183 |
|